Sigrid Stroobants
Sigrid Stroobants
Unknown affiliation
Verified email at uantwerpen.be
Title
Cited by
Cited by
Year
Revised response criteria for malignant lymphoma
BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ...
Journal of clinical oncology 25 (5), 579-586, 2007
41822007
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
AT van Oosterom, I Judson, J Verweij, S Stroobants, ED di Paola, ...
The Lancet 358 (9291), 1421-1423, 2001
14642001
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ...
Journal of Clinical Oncology 25 (5), 571-578, 2007
14352007
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
R Boellaard, MJ O’Doherty, WA Weber, FM Mottaghy, MN Lonsdale, ...
European journal of nuclear medicine and molecular imaging 37 (1), 181, 2010
12172010
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
R Boellaard, R Delgado-Bolton, WJG Oyen, F Giammarile, K Tatsch, ...
European journal of nuclear medicine and molecular imaging 42 (2), 328-354, 2015
12082015
Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO
JY Blay, S Bonvalot, P Casali, H Choi, M Debiec-Richter, AP Dei Tos, ...
Annals of Oncology 16 (4), 566-578, 2005
9372005
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
P Flamen, A Lerut, E Van Cutsem, W De Wever, M Peeters, S Stroobants, ...
Journal of Clinical Oncology 18 (18), 3202-3210, 2000
6442000
18FDG-positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec«)
S Stroobants, J Goeminne, M Seegers, S Dimitrijevic, P Dupont, J Nuyts, ...
European journal of cancer 39 (14), 2012-2020, 2003
6032003
Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Isá…
K Spaepen, S Stroobants, P Dupont, S Van Steenweghen, J Thomas, ...
Journal of Clinical Oncology 19 (2), 414-419, 2001
5602001
Prognostic Importance of the Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancerá…
JF Vansteenkiste, SG Stroobants, PJ Dupont, PR De Leyn, EK Verbeken, ...
Journal of Clinical Oncology 17 (10), 3201-3206, 1999
5131999
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
JF Vansteenkiste, SG Stroobants, PR De Leyn, PJ Dupont, J Bogaert, ...
Journal of Clinical Oncology 16 (6), 2142-2149, 1998
5131998
Imaging biomarker roadmap for cancer studies
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
4332017
Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch
D Blockmans, S Stroobants, A Maes, L Mortelmans
The American journal of medicine 108 (3), 246-249, 2000
3772000
The impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
LJ Vanuytsel, JF Vansteenkiste, SG Stroobants, PR De Leyn, W De Wever, ...
Radiotherapy and Oncology 55 (3), 317-324, 2000
3552000
Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms
J Nuyts, P Dupont, S Stroobants, R Benninck, L Mortelmans, P Suetens
IEEE transactions on medical imaging 18 (5), 393-403, 1999
3311999
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer
CJ Hoekstra, SG Stroobants, EF Smit, J Vansteenkiste, H van Tinteren, ...
J Clin Oncol 23 (33), 8362-70, 2005
2982005
Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer
P Flamen, S Stroobants, E Van Cutsem, P Dupont, G Bormans, ...
Journal of clinical oncology 17 (3), 894-894, 1999
2901999
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-doseá…
K Spaepen, S Stroobants, P Dupont, P Vandenberghe, J Maertens, ...
Blood 102 (1), 53-59, 2003
2682003
Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
AT van Oosterom, IR Judson, J Verweij, S Stroobants, H Dumez, ...
European Journal of Cancer 38, S83-S87, 2002
2652002
Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinalá…
P De Leyn, S Stroobants, W De Wever, T Lerut, W Coosemans, G Decker, ...
Journal of Clinical Oncology 24 (21), 3333-3339, 2006
2412006
The system can't perform the operation now. Try again later.
Articles 1–20